‘In terms of the impact that the Omnipod 5 has had, I was somebody whose background fluctuated so much, especially in the evening when I was asleep, pretty much most nights I would have a hypo. So having that extra level of security for me with the algorithm just doing it’s thing in the background is honestly life changing.’
Timothie J, (aka Grace Shush) Omnipod user since 2022, Omnipod 5 user since 2023.
SmartAdjust™ technology is the brains behind the Omnipod 5 System, helping to protect against highs and lows.1 The System predicts where glucose values will be in 60 minutes and automatically increases, decreases, or pauses insulin every 5 minutes based on your sensor value and trend. Bolus doses can be given for meals using the Omnipod 5 Controller.
References:
- Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9 years with type 1 diabetes.
SmartAdjust™ technology (proactively) helps to correct highs and protect from lows (every 5 minutes). Compatible sensor required for automated mode. Sensors are sold and prescribed separately. Compatibility may vary per country.
The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older requiring insulin.
The Omnipod 5 System is intended to operate as an automated insulin delivery system when used with compatible Continuous Glucose Monitors (CGM). When in automated mode, the Omnipod 5 system is designed to assist people with type 1 diabetes in achieving glycaemic targets set by their healthcare providers. It is intended to modulate (increase, decrease or pause) insulin delivery to operate within predefined threshold values using current and predicted CGM values to maintain blood glucose at variable target glucose levels, thereby reducing glucose variability. This reduction in variability is intended to lead to a reduction in the frequency, severity, and duration of both hyperglycaemia and hypoglycaemia.
The Omnipod 5 System can also operate in a manual mode that delivers insulin at set or manually adjusted rates.
The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is indicated for use with NovoLog®/NovoRapid®, Humalog®/Liprolog®, Trurapi®/Truvelog®/Insulin aspart Sanofi®, Kirsty®, and Admelog/Insulin lispro Sanofi U-100 insulin.
Warning: SmartAdjust™ technology should NOT be used by anyone under the age of 2 years old. SmartAdjust™ technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.
The Omnipod® 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod® 5 System according to instructions, are taking hydroxyurea as it could lead to falsely elevated CGM values and result in over-delivery of insulin that can lead to severe hypoglycaemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod® 5 System, including alerts, alarms, and reminders. Device components including the Pod, CGM transmitter, and CGM sensor must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment. In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components.
©2025 Insulet Corporation. Omnipod, the Omnipod logo, and Simplify Life are trademarks or registered trademarks of Insulet Corporation in the United States of America and other various jurisdictions. All rights reserved. Dexcom, Dexcom G6 and Dexcom G7 are registered trademarks of Dexcom, Inc. and used with permission. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. All other trademarks are the property of their respective owners. The use of third- party trademarks does not constitute an endorsement or imply a relationship or other affiliation. Insulet International Limited,1 King Street, 5th Floor, Hammersmith, London W6 9HR . Please see Omnipod.com/safety for important safety information. INS-OHS-03-2025-00277 v1.0